📰 Abt News
Page 17 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 11, 2024
Janiczek Wealth Management LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 38.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,653 shares of the healthcare product maker’s stock after acquiring an additional 1,022 shares during the […]
April 11, 2024
AIMZ Investment Advisors LLC lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% during the 4th quarter, Holdings Channel reports. The firm owned 17,396 shares of the healthcare product maker’s stock after selling 198 shares during the period. AIMZ Investment Advisors LLC’s holdings in Abbott Laboratories were worth $1,915,000 as […]
April 11, 2024
Cerity Partners LLC grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 35.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,062,319 shares of the healthcare product maker’s stock after acquiring an additional 278,477 shares during the quarter. […]
April 11, 2024
Financial Counselors Inc. lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,960 shares of the healthcare product maker’s stock after purchasing an additional 964 shares during the quarter. […]
April 11, 2024
Luts & Greenleigh Group Inc. trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,765 shares of the healthcare product maker’s stock after selling 244 shares during the period. Abbott Laboratories comprises […]
April 9, 2024
Aull & Monroe Investment Management Corp trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,551 shares of the healthcare product maker’s stock after selling 553 shares during the quarter. […]
April 9, 2024
Dearborn Partners LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 362,774 shares of the healthcare product maker’s stock after selling 5,475 shares during the period. Dearborn Partners LLC’s holdings […]
April 9, 2024
Arcblock (ABT) traded up 0.7% against the dollar during the 1 day period ending at 11:00 AM ET on April 9th. In the last seven days, Arcblock has traded 67.7% higher against the dollar. Arcblock has a total market capitalization of $278.98 million and approximately $7.05 million worth of Arcblock was traded on exchanges in […]
April 9, 2024
Moseley Investment Management Inc. bought a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,946 shares of the healthcare product maker’s stock, valued at approximately $214,000. A number of other large investors have also recently […]
April 9, 2024
Aull & Monroe Investment Management Corp trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 19,551 shares of the healthcare product maker’s stock after selling 553 shares during the quarter. Aull & […]